• 1
    O’Conor VJ Jr, Dawson-Edwards P. Role of ureter in renal transplantation: I. Studies of denervated ureter with particular reference to ureteroureteral anastomosis. J Urol 1959; 82: 56672
  • 2
    Morita T, Wada I, Saeki H, Tsuchida S, Weiss RM. Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs. J Urol 1987; 137: 1325
  • 3
    Malin JM Jr, Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br J Urol 1970; 42: 1714
  • 4
    Wanajo I, Tomiyama Y, Yamazaki Y, Kojima M, Shibata N. Pharmacological characterization of β-adrenoceptor subtypes mediating relaxation in porcine isolated ureteral smooth muscle. J Urol 2004; 172: 11559
  • 5
    Park YC, Tomiyama Y, Hayakawa K et al. Existence of a β3-adrenoceptor and its functional role in the human ureter. J Urol 2000; 164: 136470
  • 6
    Obara K, Takeda M, Shimura H et al. Alpha-1 adrenoceptor subtypes in the human ureter. Characterization by RT-PCR and in situ hybridization. J Urol 1996; 155 (Suppl.): 472A
  • 7
    Sigala S, Dellabella M, Milanese G et al. Evidence for the presence of α1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 2005; 24: 1428
  • 8
    Hieble JP, Bylund DB, Clarke DE et al. International Union of Pharmacology. X. Recommendation for nomenclature of alpha1-adrenoceptors: consensus update. Pharmacol Rev 1995; 47: 26770
  • 9
    Kobayashi S, Tang R, Shapiro E, Lepor H. Characterization and localization of prostatic alpha 1-adrenoceptors using radioligand receptor binding on slide-mounted tissue section. J Urol 1993; 150: 20026
  • 10
    Malloy BJ, Price DT, Price RR et al. α1-Adrenergic subtypes in human detrusor. J Urol 1998; 160: 93743
  • 11
    Muramatsu I, Taniguchi T, Okada K. Tamsulosin: α1-Adrenoceptor subtype-selectivity and comparison with terazosin. Jpn J Pharmacol 1998; 78: 3315
  • 12
    Cervenakov I, Fillo J, Mardiak J, Kopecny M, Smirala J, Lepies P. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker tamsulosin. Int Urol Nephrol 2002; 34: 259
  • 13
    Bhagat SK, Chacko KN, Kerke NS, Gopalakrishnan G, Antonisamy B, Devasia A. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteric calculi? J Urol 2004; 177: 21858
  • 14
    Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 2003; 170: 22025
  • 15
    Resim S, Ekerbicer HC, Ciftci A. Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology 2005; 66: 9458
  • 16
    Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 2005; 174: 16772
  • 17
    Troxel SA, Jones AW, Maglola L, Benson JS. Physiologic effect of nifedipine and tamsulosin on contractility of distal ureter. J Endourol 2006; 20: 5658
  • 18
    Nakada SY, Coyle TL, Ankem MK, Moon TD, Jerde TJ. Doxazosin relaxes ureteral smooth muscle and inhibits epinephrine-induced ureteral contractility in vitro. Urology 2007; 70: 81721
  • 19
    Davenport K, Timoney AG, Keeley FX. A comparative in vitro study to determine the beneficial effect of calcium-channel and α1-adrenoceptor antagonism on human ureteric activity. BJU Int 2006; 98: 6515
  • 20
    Matsushima H, Kamimura H, Soeishi Y, Watanabe T, Higuchi S, Tsunoo M. Pharmacokinetics and plasma protein binding of tamsulosin hydrochloride in rats, dogs, and humans. Drug Metab Dispos 1998; 26: 2405